baber/WOPTO huggingface dataset:
Patent NZ-587280-A (NZ)
Title: Booster seat improvements
Inventor: LUMLEY MIKE
IPC: B60R22/10
Filed: 2010-08-09
Abstract: A booster seat 1 for use with a seatbelt equipped vehicle seat 54 comprises a base portion and a vehicle seat belt guide 8. The seatbelt 40 comprises a lap belt 42 and a sash belt 44. The booster seat 1 comprises a base portion of such a thickness as to position a booster seat occupant such that the sash belt 44 passes over the shoulder of the occupant. The vehicle seat belt guide 8 is adapted to retain a portion of the lap belt 42 at a location between the legs of a booster seat occupant so that the lap belt 42 is retained below an occupant's abdomen and above or in contact with the occupant's thighs. The thickness of the base portion is greater than the thickness of the seat belt guide 8.
Patent NZ-591486-A (NZ)
Title: Call routing methods and systems based on multiple variable standardized scoring and shadow queue
Inventor: CHISHTI ZIA
IPC: G06Q30/00
Filed: 2009-08-19
Abstract: 591486 Disclosed is a system for routing callers to agents in a call-centre routing environment. The system is comprised of a collector, a matching engine, a routing engine and a reporting engine. The collector is configured to obtain demographic data and/or psychographic data associated with callers in a set of callers and agents in a set of agents. The matching engine is configured with one routing algorithm to match callers of a first portion of the set of callers with the agents in the set of agents, based at least in part on the demographic data and/or psychographic data associated with the callers in the first portion of callers and the agents in the set of agents, to increase the chance of an optimal interaction. The routing engine is configured to connect the callers in the first portion of callers to agents in the set of agents based at least in part on results from the one routing algorithm. The matching engine is further configured with a different routing algorithm to match callers in a second portion of the set of callers to agents in the set of agents using the different routing algorithm. The routing engine is further configured to connect the respective callers in the second portion of the callers to respective agents in the set of agents based on results from the different routing algorithm. The reporting engine is configured to generate a report or display data comparing outcome data from using the one routing algorithm for matching against outcome data from using the different routing algorithm for matching.
Patent NZ-592174-A (NZ)
Title: A method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
Inventor: WONG BING LOU
IPC: A23J1/06
Filed: 2011-04-11
Abstract: Disclosed is a method for the preparation of a highly purified and heat stable cross-linked nonpolymeric tetrameric hemoglobin suitable for use in mammals without causing renal injury and vasoconstriction is provided. A high temperature and short time heat processing step is performed to remove undesired dimeric form of hemoglobin, uncross-linked tetrameric hemoglobin, and plasma protein impurities effectively. Addition of N-acetyl cysteine after heat treatment and optionally before heat treatment maintains a low level of met-hemoglobin.
Patent NZ-593144-A (NZ)
Title: A valve assembly having a unitary valve sleeve
Inventor: WEIDE KRISTOPHER
IPC: F16K3/00
Filed: 2009-12-07
Abstract: 593144 A sleeve for sealing a gate valve. The sleeve has a body of unitary construction defining a flange portion which is configured to engage a valve housing, and a sealing portion which is configured to engage a gate portion of the valve. The body has a generally circular shape defining an axially extending passage. The body has an inner wall and an outer wall, a first curved surface of the inner wall extends around the sealing portion. The first curved surface engages the gate portion of the valve. A second curved surface of the inner wall is contiguous with the first curved surface. The second curved surface extends around the inner wall and is concave relative to the body. A support member is encapsulated in the body between the inner surface and the outer surface. The support member has a surface radially extending in a direction from the inner surface to the outer surface so as to support the sealing portion in an axial direction. The support member has a tapered lip portion disposed along the sealing portion. The tapered lip portion has first and second flat tapering portions. The first flat tapering portion is configured to engage a body portion of the valve. The second flat tapering portion is continuous with the first curved surface. The first flat tapering portion is angled with respect to an axis of the axially extending passage.
Patent NZ-594350-A (NZ)
Title: Breathing assistance device comprising a gas regulating valve and associated breathing assistance method
Inventor: CHALVIGNAC PHILIPPE
IPC: A61M16/20
Filed: 2006-05-02
Abstract: A gas regulating valve 60 adapted to be interposed in a gas transmission duct of a breathing assistance device at a location proximal to the patient has a casing including a gas flow duct 61 and a housing 613, a gas leakage orifice 617 formed in the housing to allow flow of gas from within the duct to atmosphere via the housing, and an obstruction element 62 within the housing. The proximal 612 and distal 611 ends of the gas flow duct are coupled to the gas transmission duct going to the patient and to the gas source respectively so that the gas flow duct receives a flow of breathable gas between the source and the patient. A first side of the housing is in communication with the gas flow duct via the leakage orifice. The obstruction element 62 includes a movable element 622 which acts on a protection element 625 to vary the opening of the leakage orifice in response to a signal from a controller to the obstruction element. The protection element 625, provided as a flexible membrane, also isolates the obstruction element from the gas flow duct.
Patent NZ-595417-A (NZ)
Title: Tissue closure devices, device and systems for delivery, kits and methods therefor
Inventor: HOUSER RUSSELL A
IPC: A61B17/03
Filed: 2010-04-09
Abstract: 595417 A wound closure devices, devices and systems for delivery, kits and methods therefor are disclosed. The wound closure devices can achieve wound closure in lieu of compression and can be configured to be quickly deployable by an introducer or from outside the body. The tissue closure device (70) has a distal flexible cap (670) and a stem (672). The cap includes a plurality of protrusions disposed on a distal surface (680) which provide flexibility in a first direction while resisting deflection in a second direction opposite the first direction. The stem has one end contacting a proximal surface of the distal flexible cap, wherein the distal flexible cap is formable toward an axis when deflected in the first direction. The stem further comprises a proximally positioned aperture. The distal cap and the stem are formed from a single integral piece of a bio-absorbable material.
Patent NZ-596333-A (NZ)
Title: Expanding the dynamic range of a test strip
Inventor: LIU HONGJIAN
IPC: G16H10/60
Filed: 2010-04-14
Abstract: 596333 Discloses a test strip comprising: A chromatographic strip with a first end and a second end that comprises at least a first reaction region and a second reaction region, wherein each reaction region comprises a capture agent that specifically binds the same analyte that may be present in a sample’ An absorbent pad at the first end of the chromatographic strip (a) a sample addition zone located at the second end of the strip and a buffer region located near the first end of the strip; or (b) a sample addition zone located near the first end of the strip and a buffer region located at the second end of the chromatographic strip, Wherein, the test strip allows bi-directional lateral flow.
Patent NZ-601115-A (NZ)
Title: 3,4,4a,10b-tetrahydro-1h-thiopyrano-[4,3-c]isoquinoline derivatives
Inventor: FLOCKERZI DIETER
IPC: A61K31/4365
Filed: 2010-12-15
Abstract: 601115 Disclosed are 3-[1-({ 4-[(4aR,10bR)-8,9-dialkoxy-3,4,4a,10b-tetrahydro-1H-thiopyrano[4,3-c]isoquinolin-6-yl]phenyl} carbonyl)piperidin-4-yl]-1-[(heteroaryl)methyl]-6-phenyl-thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione derivatives as represented by the general formula (I), wherein A is S, S(O) or S(O)2; either R1 is alkoxy, cycloalkoxy, cycloalkylmethoxy, or alkoxy predominantly or completely substituted by fluorine and R2 is alkoxy, cycloalkoxy, cycloalkylmethoxy, or alkoxy predominantly or completely substituted by fluorine, or R1 and R2 together form a alkylenedioxy group; R3 is a five membered heterocyclic ring, which is substituted by R4; R5 is unsubstituted phenyl, phenyl substituted by R6 or phenyl substituted by R6 and R7; or a stereoisomer of the compound. Particularly important compounds include 3-[1-({ 4-[(4aR,10bR)-9-ethoxy-8-methoxy-3,4,4a,10b-tetrahydro-1H-thiopyrano[4,3-c]isoquinolin-6-yl]phenyl} carbonyl)piperidin-4-yl]-1-[(2-ethyl-2H-tetrazol-5-yl)methyl]-6-phenyl-thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione, 3-[1-({ 3-[(4aR,10bR)-9-ethoxy-8-methoxy-3,4,4a,10b-tetrahydro-1H-thiopyrano[4,3-c]isoquinolin-6-yl]phenyl} carbonyl)piperidin-4-yl]-1-[(2-ethyl-2H-tetrazol-5-yl)methyl]-6-phenylthieno[3,2-d]pyrimidine-2,4(1H,3H)-dione and 3-[1-({ 4-[(4aR,10bR)-9-ethoxy-8-methoxy-3,4,4a,10b-tetrahydro-1H-thiopyrano[4,3-c]isoquinolin-6-yl]phenyl} carbonyl)piperidin-4-yl]-1-{ [5-(methoxymethyl)-1,3,4-oxadiazol-2-yl]methyl} -6-phenyl-thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione. Further disclosed is pharmaceutical composition comprising at least one of the compounds of formula 1 as defined above or a stereoisomer thereof together with at least one pharmaceutically acceptable auxiliary, for the treatment or prophylaxis of an acute or chronic airway disease, including interstitial lung disease, pulmonary fibrosis, cystic fibrosis, bronchial asthma, chronic bronchitis, emphysema, chronic obstructive pulmonary disease (COPO) and COPD associated with pulmonary hypertension.
Patent NZ-605874-A (NZ)
Title: Methods and compositions for cns delivery of heparan n-sulfatase
Inventor: NATOLI FARAH
IPC: A61K38/46
Filed: 2011-06-25
Abstract: Disclosed is a stable formulation comprising a heparin N-sulfatase (HNS) protein at a concentration at or greater than about 5 mg/ml, and wherein the formulation comprises no greater than 50 mM of phosphate.
Patent NZ-606186-A (NZ)
Title: Use of lactoferrin to treat proteinuria
Inventor: HOBMAN PETER
IPC: A61P13/12
Filed: 2011-06-24
Abstract: Disclosed is the use of lactoferrin in the manufacture of a medicament for treating proteinuria; wherein the proteinuria is albuminuria or microalbuminuria.
Patent NZ-608260-A (NZ)
Title: Estrous cycle monitoring by color response
Inventor: GOLDMAN DOROTHEE
IPC: C12Q1/00
Filed: 2011-08-04
Abstract: Disclosed is a method of determining the phase of an estrous cycle that a mammal is in at a given time that a biological sample is obtained from the mammal, comprising combining the biological sample obtained from the mammal with an anthocyanin pigment and flavonol pigment to induce a reaction that provides a colour response on a hydrophobic substrate, the estrus phase of the estrous cycle having a corresponding colour response to the anthocyanin pigment and the flavonol pigment that is distinguishable to an unaided human eye from the colour responses of each other phase of the estrous cycle, and correlating the corresponding colour response to the estrus phase of the estrous cycle.
Patent NZ-616050-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: C13K1/02
Filed: 2010-05-18
Abstract: The disclosure relates to the processing of biomass feedstocks (e.g., plant biomass, animal biomass, and municipal waste biomass) to produce useful products, such as fuels. For example, systems are described that can convert feedstock materials to a sugar solution, which can then be fermented to produce ethanol. Biomass feedstock is saccharified in a vessel by operation of a jet mixer, the vessel also containing a fluid medium and a saccharifying agent, wherein the the longitudinal axis of the jet mixer is offset laterally from the center of the the vessel.
Patent NZ-627582-A (NZ)
Title: Compact eye-tracked head-mounted display
Inventor: HUA HONG
IPC: G02B27/02
Filed: 2013-01-24
Abstract: Disclosed is an eye-tracked head-mounted display. The eye-tracked head-mounted display comprises a micro-display (520), a first plane, an image sensor (560) and display optics. The micro-display (520) generates an image to be viewed by a user. The micro-display (520) has a display optical path and an exit pupil (512) associated therewith. The first plane located at the micro-display (520) and a second plane located at the exit pupil (512). The image sensor (560) configured to receive reflected optical radiation from the second plane reflected from a user’s eye (10). The image sensor (560) having a sensor optical path associated therewith. The display optics is disposed in optical communication with the micro-display along the display optical path and in optical communication with the image sensor (560) along the sensor optical path. The display optics having a selected surface closest to the micro-display and the image sensor (560), the display optics located relative to the micro-display and image sensor (560) such that the display and image sensor (560) optical paths impinge upon differing respective portions of the selected surface.
Patent NZ-629918-A (NZ)
Title: High speed communication jack
Inventor: ROBINSON BRETT D
IPC: H01R13/6466
Filed: 2013-01-24
Abstract: Disclosed is a high speed communication jack. The high speed communication jack includes a housing, a shielding case surrounding the housing, a flexible circuit board between the shielding case and the housing. The housing including a port for accepting a plug, and the port including a plurality of pins each connected to a corresponding signal line in the plug. The housing having a substrate (402), a plurality of vias (406, 408, 410, 412, 414, 416, 418, 420) extending through the substrate (402) with each via being configured to accommodate a pin on the housing, a plurality of traces on a first side of the substrate (402), with each trace extending from a corresponding one of the plurality of vias (406, 408, 410, 412, 414, 416, 418, 420), and a shielding plane on a second side of the substrate (402) opposite the first side of the substrate (402).
Patent NZ-702339-A (NZ)
Title: Switch, transmission method, program, and recording medium
Inventor: YAMAMOTO HIROYUKI
IPC: H04L12/44
Filed: 2013-02-15
Abstract: The present invention provides a switch (20a) that transmits an LACP frame to a server (10). Another switch (20b) also transmits another LACP frame to the server (10). The LACP frame and the other LACP frame are for making a request for link aggregation to the server (10). A system identifier for the LACP frame is the same as the system identifier for the other LACP frame. A plurality of bypass ports (eth3, eth4) are provided. A faulty aggregation group identifier (0x00BB) that is associated with a faulty port (eth0) is associated with a port identifier (eth3) for a selected bypass port. Port identifiers for different selected bypass ports are associated with different faulty aggregation group identifiers.
Patent NZ-704727-A (NZ)
Title: Tris(hetero)arylpyrazoles and use thereof
Inventor: KLENKE BURKHARD
IPC: C07D487/04
Filed: 2013-08-16
Abstract: The present invention relates to novel tris(hetero)arylpyrazoles, where U, V, W and X stand for nitrogen or carbon, and R1 and R2 stand for substituted phenyl or pyridyl which can be substituted, such as the compound 4-{ 5-[3-chloro-5- (trifluoromethoxy)-phenyl]-1-(pyridine-3-yl)-1H-pyrazole-3-yl} -5,6-dihydro-6H-pyrrolo[3,4-d]pyrimidin-7-one, and to processes for preparation thereof. The present invention also relates to the use of the tris(hetero)arylpyrazoles for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of retroviral disorders such as human immunodeficiency virus (HIV), in man and/or animals.
Patent NZ-706202-A (NZ)
Title: Peptide antagonists of the vasopressin-2 receptor
Inventor: GILLES NICOLAS
IPC: C07K14/46
Filed: 2013-09-17
Abstract: Addressing the need for antagonists of vasopressin-2 receptor (V2R) with improved properties for therapeutic use, the present invention relates to proteins derived from a snake venom basic protease inhibitor, having antagonist activity and to uses thereof. In an embodiment, provided herein is an isolated protein, comprising an amino acid sequence which is at least 70 % identical to residues 1 to 57 of SEQ ID NO: 1, and which comprises a motif X1X2X3X4 in positions 15 to 18 of SEQ ID NO: 1, wherein X1 is an asparagine (N), X2 is a glycine (G), X3 and X4 are hydrophobic amino acids, and comprises one to three disulfide bonds between two cysteine residues, and wherein said protein has V2R antagonist activity.
Patent NZ-712924-A (NZ)
Title: Use of a dietary fibre supplement in a food formulation
Inventor: BALL MALCOLM
IPC: A23L29/262
Filed: 2014-04-07
Abstract: Use of dietary fibre material extracted from sugarcane in the manufacture of a food product that is formulated to ameliorate the effects of intestinal tract disorders such as Coeliac’s disease and Irritable Bowel Syndrome (IBS).
Patent NZ-714410-A (NZ)
Title: Trehalose and dextran-containing solution for transplanting mammalian cells
Inventor: WADA TAMAKI
IPC: C12N5/0783
Filed: 2014-06-18
Abstract: The present invention addresses the problem of providing a method for storing mammalian cells for 3 to 14 days, with the use of a solution for cell transplantation by which cell death can be effectively suppressed during the storage of the mammalian cells, and the solution for cell transplantation. The present invention is characterised in that mammalian cells are stored in a physiological aqueous solution for cell transplantation, said solution containing 2.0-6.0 (w/v)% of trehalose or a salt of the same and 4.0-7.0 (w/v)% of dextran or a salt of the same. Owing to the effects of the trehalose compound and dextran compound contained in the physiological aqueous solution for cell transplantation, a lowering in the survival rate of the mammalian cells can be suppressed in the case of storing the mammalian cells over a period of 3 to 14 days. The physiological solution is preferably selected from the group consisting of lactate Ringer solution, physiological saline, Ringer solution and acetate Ringer solution. Particularly preferable examples thereof include lactate Ringer solution and physiological saline.
Patent NZ-733878-A (NZ)
Title: Dewatering tank
Inventor: JEFFERY PAUL WAYNE
IPC: C02F11/12
Filed: 2016-02-12
Abstract: The present disclosure provides a dewatering tank that is configured to retain fines in suspension. The tank comprises a floor portion that has a downward inclination. The tank further comprises a sump that is located such that the floor portion inclines towards the sump. The tank has an inlet for admission of water containing the fines and an outlet that is adapted for connection with a pump to discharge the water containing the fines from the tank and that is located in the sump. The tank is arranged such that the water flows from the inlet to the outlet. The tank comprises a wall or cover portion that is positioned to divert a flow of the water away from a direct flow direction from the inlet to the outlet in a manner such that turbulences are induced and fines that may otherwise settle in the sump and on the floor portion are suspended.
Patent NZ-736756-A (NZ)
Title: Zone cooling in a refrigerated merchandiser
Inventor: TWOHY RAYMOND
IPC: F25D17/08
Filed: 2014-12-23
Abstract: A refrigerated merchandiser including a case that defines a product display area and an access opening. The case has an air inlet and an air outlet, and a passageway fluidly connects the air inlet with the air outlet to direct a refrigerated airflow across the customer access opening in the form of an air curtain. The merchandiser also includes shelves that are coupled to the case. Each shelf includes an inlet, an outlet, a fan unit disposed in the shelf, and a heat exchanger. The fan unit is in communication with the passageway to draw air through the inlet to direct a portion of the airflow through the shelf toward the outlet. The heat exchanger is disposed in the shelf to cool the airflow in the shelf to provide independent zone cooling to a predetermined region of the product display area.
Patent NZ-758528-A (NZ)
Title: Bicyclic heterocycle compounds and their uses in therapy
Inventor: HOWARD STEVEN
IPC: A61P35/00
Filed: 2014-12-19
Abstract: Intermediates used in the process of preparing bicyclic heterocycle compounds of formula (I), which are IAP (inhibitor of apoptosis) antagonists suitable for the treatment of diseases mediated by IAP.
Patent NZ-759625-A (NZ)
Title: Apparatus and method for fluid caching
Inventor: COX-MURANAMI WESLEY
IPC: G01N37/00
Filed: 2019-01-10
Abstract: Disclosed is an microfluidic apparatus that aims to optimise the storage of reagent fluids and reducing pump times of the reagents. The apparatus for directing fluid into and out of a fluidic device includes two or more fluid prime channels connected to a fluid inlet of the fluidic device, a flow control valve for each fluid prime channel to control flow between the fluid prime channel and the fluid inlet, one or more outlet channels connected to a fluid outlet of the fluidic device, and a flow control valve for each outlet channel to control flow between the fluid outlet and the associated outlet channel. There is a third fluid that passes through a bypass channel that is connected to the fluid prime channel. The apparatus includes a plate that is rotatable about an axis of rotation and a plurality of fluid compartments disposed on the plate, each compartment having a fluid exit port disposed at a common radial distance from the axis of rotation and positioned to align with the fluid inlet as the plate rotates about the axis of rotation.
Patent NZ-767500-A (NZ)
Title: Flow Generator Message System
Inventor: DANTANARAYANA MUDITHA PRADEEP
IPC: A61M16/00
Filed: 2006-10-13
Abstract: A flow generator (10) for delivering breathable gas to a patient includes a motor (12), operation sensors (34), a processor (18) and a user interface (20). The processor (18) is configured to: receive the signals from the at least one operation sensor; during operation of the flow generator to treat the patient, detect a leak based on the signals from the at least one operation sensor; in response to the detection of the leak, generate a first message; control the communication system to provide the first message to a person; during operation of the flow generator to treat the patient, further detect the leak based on the signals from the at least one operation sensor; detect a duration of the leak based on the signals from the at least one operation sensor; in response to the further detection of the leak and based on the duration of the leak, generate a second message, wherein the second message is changed from the first message; and control the communication system to provide the second message to a recipient.